Acid active receptor-specific peptide ligand for in vivo tumor-targeted delivery.


Targeting therapy of tumors in their early stages is crucial to increase the survival rate of cancer patients. Currently most drug-delivery systems target the neoplasia through the tumor-associated receptors overexpressed on the cancer cell membrane. However, the expression of these receptors on normal cells and tissues is inevitable, which leads to… (More)
DOI: 10.1002/smll.201300279


  • Presentations referencing similar topics